Company / Shares Outstanding
ELITE PHARMACEUTICALS INC /NV/ Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
1.1B
FY2025
5-year range
840.4M / 1.1B
FY2021-FY2025
Trend
+5.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding has increased for 6 consecutive years, from 802526761.00 in FY2019 to 1068273108.00 in FY2025.
Based on SEC 10-K filings.
1068273108.00 in FY2025 with a 5-year CAGR of +5.3%.
Increased from 1011281988.00 to 1068273108.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +1.9%
- 5-Year CAGR
- +5.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- ELITE PHARMACEUTICALS INC /NV/'s shares outstanding has grown for 6 consecutive years.
- In FY2025, shares outstanding increased 5.4% year-over-year.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 1.1B | +5.4% |
| FY2024 | 1.0B | +0.3% |
| FY2023 | 1.0B | +0.2% |
| FY2022 | 1.0B | +20.1% |
| FY2021 | 840.4M | +1.9% |
| FY2020 | 824.8M | +2.8% |
| FY2019 | 802.5M | -13.5% |
| FY2018 | 927.9M | +30.4% |
| FY2017 | 711.4M | +12.7% |
| FY2016 | 631.1M | +12.7% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026